Binding model of fisetin and human c-Jun NH2-terminal kinase 1 and its anti-inflammatory activity

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Fisetin is a naturally occurring flavonoid with some anti-cancer and anti-inflammation capabilities. In this study, we perform docking studies between human c-Jun N-terminal kinase 1 (JNK 1) and fisetin and proposed a binding model of fisetin and JNK 1, in which the hydroxyl groups of the B ring and oxygen at the 4-position of the C ring play key roles in binding interactions with JNK. Fluorescence quenching and saturation-transfer difference (STD) NMR experiments showed that fisetin exhibits good binding affinity to JNK, 1.32 × 108 M-1. The anti-inflammatory activity of fisetin was also investigated. Fisetin significantly suppressed tumor necrosis factor, the NO production, and macrophage inflammatory cytokine release in LPS-stimulated RAW264.7 mouse macrophages. We found that the anti-inflammatory cascade of fisetin was mediated through the JNK, and cyclooxygenase (COX)-2 pathways. Our findings suggest the potential of fisetin as an anti-inflammatory agent.

Cite

CITATION STYLE

APA

Jnawali, H. N., Lee, E., Jeong, K. W., Heo, Y. S., & Kim, Y. (2013). Binding model of fisetin and human c-Jun NH2-terminal kinase 1 and its anti-inflammatory activity. Bulletin of the Korean Chemical Society, 34(9), 2629–2634. https://doi.org/10.5012/bkcs.2013.34.9.2629

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free